Acylated piperidine derivatives as melanocortin-4 receptor agonists

Details for Australian Patent Application No. 2005275232 (hide)

Owner Merck & Co., Inc.

Inventors Guo, Liangqin; Nargund, Ravi P.; Ye, Zhixiong; Barakat, Khaled J.; Sebhat, Iyassu K.; Liu, Jian

Agent Spruson & Ferguson

Pub. Number AU-A-2005275232

PCT Pub. Number WO2006/019787

Priority 60/588,494 16.07.04 US

Filing date 13 July 2005

Wipo publication date 23 February 2006

International Classifications

A61K 31/454 (2006.01)

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/019787 Priority application(s): WO2006/019787

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005275237-Medical waste disposal device

2005275220-Adduct of fluorescent dye and tumor avid tetrapyrrole